Product Name: Reliance Omalirel (Omalizumab) Injection Brand Name: Omalirel Composition: Omalizumab Strength: 150 mg per vial Packaging Type: Lyophilized Powder in Vial Packaging Size: 1 Vial per Pack Prescription Required: Yes Usage/Application: Hospital, Clinical Form: Injectable Solution Country of Origin: India
Product Description: Omalirel is a humanized IgG1k monoclonal antibody that selectively binds to human immunoglobulin E (IgE). It binds to the FcR1 epitope of human IgE, preventing human IgE from binding to its receptor on mast cells and basophils; thus inhibiting the histamine release response normally triggered by exposure to allergens.
Key Features:
Manufactured by Reliance Life Sciences Pvt. Ltd.
Available in 150 mg strength
Comes as a lyophilized powder for reconstitution
Suitable for subcutaneous administration under medical supervision
Pack includes sterile water for injection (WFI), syringes, needles, and alcohol swabs
Manufactured in GMP-compliant facilities
Indications:
Moderate to severe persistent asthma in adults and children
Chronic idiopathic urticaria (hives) in adults and children who remain symptomatic despite H1 antihistamine treatment
Dosage and Administration: Omalirel is administered via subcutaneous injection. The dosage and frequency depend on the patient's body weight and the specific condition being treated. The first three doses are typically given under medical supervision, after which patients may be trained for at-home administration.
Storage: Store below 25C. Protect from light. Do not refrigerate.